See today's BioWorld
To read the full story, subscribe or sign in.

GlobeImmune, Celgene Form $540M Cancer Partnership

May 18, 2009
By Catherine Hollingsworth
Celgene Corp. will pay GlobeImmune Inc. $40 million up-front to gain access to all of the company's cancer drug programs. (BioWorld Today)
BioWorld